Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection
NCT04456413
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
21
Enrollment
OTHER
Sponsor class
Stopped
Lack of accrual
Conditions
COVID-19
Interventions
BIOLOGICAL:
Convalescent Plasma
OTHER:
Best Supportive Care
Sponsor
Hackensack Meridian Health
Collaborators
[object Object]